Results 31 to 40 of about 10,145 (225)

Hospital mortality and survival according to duration of HFNC (days).

open access: yes, 2022
Hospital mortality and survival according to duration of HFNC (days).
Marion Faucher (4281526)   +10 more
core   +1 more source

Effect of high-flow nasal cannula(HFNC)to COVID-19- associated pneumonia -outcome of our hospital - [PDF]

open access: yes, 2021
「背景」当院では重症化回避を目的にCOVID-19肺炎に早期HFNC 管理をしている。「目的」COVID-19肺炎に対するHFNC の有効性と課題を調査。「方法」1年間にHFNC を導入した中等症Ⅱ以上のCOVID-19肺炎を対象に転帰と それに関連した院内感染を検討した。「結果」11/13人がHFNC のみで改善し侵襲的人工呼吸管理を回避した。院内感染は2/57人に認めた。「結論」COVID-19肺炎に対する早期HFNC 導入は重症化回避の治療戦略として有効である。journal ...
坂脇, 園子   +8 more
core  

The Outcome Impact of Early vs Late HFNC Oxygen Therapy in Elderly Patients with COVID-19 and ARDS [PDF]

open access: yes, 2020
Coronavirus disease-2019 (COVID-19) has rapidly spread worldwide. High-flow nasal cannula therapy (HFNC) is a major oxygen supporting therapy for severely ill patients, but information regarding the timing of HFNC application is scarce, especially in ...
Sun, Xiaocong   +17 more
core   +1 more source

A Novel Risk-Stratification Models of the High-Flow Nasal Cannula Therapy in COVID-19 Patients With Hypoxemic Respiratory Failure

open access: yesFrontiers in Medicine, 2020
Background: High-flow nasal cannula (HFNC) has been recommended as a suitable choice for the management of coronavirus disease 2019 (COVID-19) patients with acute hypoxemic respiratory failure before mechanical ventilation (MV); however, delaying MV with
Jiqian Xu   +26 more
doaj   +1 more source

Use of high flow nasal cannula as a modality of acute respiratory failure due to COVID-19

open access: yesGülhane Tıp Dergisi, 2022
Oxygen (O2) therapy is the first-line therapy for acute respiratory distress with hypoxemia due to Coronavirus disease-2019 (COVID-19). High-flow nasal cannula (HFNC) therapy represents one of the O2 therapy alternative modalities.
Kristin Purnama Dewi   +4 more
doaj   +1 more source

Diagnostic performance of ROX index cut-offs in determining HFNC failure.

open access: yes, 2023
Diagnostic performance of ROX index cut-offs in determining HFNC failure.
Todspol Lertwattanachai (16412797)   +4 more
core   +1 more source

SpO2/FiO2 as a predictor of high flow nasal cannula outcomes in children with acute hypoxemic respiratory failure

open access: yesScientific Reports, 2021
The high-flow nasal cannula (HFNC) is a useful treatment modality for acute hypoxemic respiratory failure (AHRF) in children. We compared the ability of the oxygen saturation to fraction of inspired oxygen ratio (S/F) and arterial oxygen partial pressure
Ga Eun Kim   +9 more
doaj   +1 more source

Comparison of HFNC ventilation systems [PDF]

open access: yes, 2020
Vysokoprůtoková zvlhčená nosní kanyla (HFNC, High flow Nasal Cannula) je neinvazivní metoda kyslíkové terapie, kdy je zvlhčená a ohřátá směs plynů podávána nosní kanylou spontánně dýchajícímu pacientovi.
Michaela Soukopová
core  

Number of daily HFNC failure in patients with COVID-19 associated ARDS.

open access: yes, 2023
Number of daily HFNC failure in patients with COVID-19 associated ARDS.
Todspol Lertwattanachai (16412797)   +4 more
core   +1 more source

The use of respiratory rate-oxygenation index to predict failure of high-flow nasal cannula in patients with coronavirus disease 2019-associated acute respiratory distress syndrome: A retrospective study.

open access: yesPLoS ONE, 2023
Patients with mild-to-moderate coronavirus disease 2019 (COVID-19)-associated acute respiratory distress syndrome (ARDS) can be treated with a high-flow nasal cannula (HFNC).
Sujaree Poopipatpab   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy